Literature DB >> 12412786

Fracture risk in primary hyperparathyroidism.

Sundeep Khosla1, Joseph Melton.   

Abstract

A key component in the decision to perform surgery on patients with primary hyperparathyroidism (HPT) is their skeletal status. Consequently, fracture risk in these patients has been investigated in a number of observational studies. Our group reported on a population-based cohort of residents from Rochester, MN, with primary HPT recognized during a 28-year period (1965-1992). The majority of these patients were asymptomatic, and most (77%) were managed conservatively. By contrast, a recent Danish study reported on a cohort of 674 patients, all of whom had surgery for primary HPT. Nonetheless, the risk of fracture was increased remarkably similarly in the two populations: vertebrae, approximately 3-fold; forearm, approximately 2-fold; hip, approximately 1.5-fold; and all fractures, approximately 1.5-fold. In both studies, parathyroid surgery seemed to have a protective effect. These (and previous studies) indicate that overall fracture risk is increased in primary HPT patients. An increase in forearm fracture risk is a relatively uniform finding and is consistent with known effects of parathyroid hormone (PTH) on cortical bone. However, the increase in vertebral fracture risk seen in most (but not all) studies does not fit with the observation that cancellous bone mass/structure is preserved in primary HPT patients. Based on these findings, future directions for research include (1) rigorously testing, in prospective studies, whether vertebral fracture risk is, in fact, increased in this disorder, and if so, determining the possible biomechanical mechanism(s) for this increase; and (2) testing whether the trend to increased hip fracture risk seen in some studies is real and whether it is more closely linked to cervical or intertrochanteric fractures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412786

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  Weight loss, articular pain and bone fractures: neoplastic disease or malabsorption syndrome?

Authors:  Davide Lazzarini; Cesare Cangiotti; Sabrina Gerboni; Luca Morolli; Giorgio Ioli
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1.

Authors:  P H Kann; D Bartsch; P Langer; J Waldmann; P Hadji; A Pfützner; J Klüsener
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

Review 3.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 4.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

5.  Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

Authors:  Masanobu Ohishi; Riccardo Chiusaroli; Michael Ominsky; Frank Asuncion; Clare Thomas; Richa Khatri; Paul Kostenuik; Ernestina Schipani
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

6.  Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women.

Authors:  A W Popp; C Senn; O Franta; M A Krieg; R Perrelet; K Lippuner
Journal:  Osteoporos Int       Date:  2008-12-19       Impact factor: 4.507

Review 7.  Asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

8.  Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism.

Authors:  Ruth Zoehrer; David W Dempster; John P Bilezikian; Hua Zhou; Shonni J Silverberg; Elizabeth Shane; Paul Roschger; Eleftherios P Paschalis; Klaus Klaushofer
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

9.  Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

10.  Asymptomatic primary hyperparathyroidism: a commentary on the revised guidelines.

Authors:  Aliya A Khan; John P Bilezikian; John T Potts
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.